Search for: "GLAXOSMITHKLINE LLC"
Results 141 - 160
of 181
Sorted by Relevance
|
Sort by Date
17 Oct 2022, 11:27 am
Glaxosmithkline LLC, 981 F.3d 1030, 1040 (Fed. [read post]
11 Jun 2019, 5:12 am
GlaxoSmithKline recently announced a $300 million deal with 23 and Me to further commercialize the latter’s genetic data to identify patients with certain rare disorders for drug development and clinical trial design. [read post]
23 Apr 2010, 8:20 am
., Bose, Brigham Young University, Cornell University, Stanford University, Duke University, Georgetown University, GlaxoSmithKline, Honeywell, Harvard University, Johnson & Johnson, Kauffman Foundation, Lockheed Martin, Massachusetts Institute of Technology (MIT), Mayo Clinic, Ortho-McNeil Pharmaceuticals Inc., Rutgers, Syngenta Biotechnology, Scripps Research Institute, U.S. [read post]
6 Sep 2012, 9:17 am
According to their website, the bid values ShangPharma, with Eli Lilly and GlaxoSmithKline (www.gsk.com) among its clients, at between $157.5 million and $176 million. [read post]
29 Aug 2012, 8:49 am
Posted by Linda TernerWhile the headlines reported colorful allegations of kickbacks to physicians, such as Hawaiian vacations and Madonna tickets, and the stunning magnitude of the largest healthcare fraud settlement and payment by a drug company , the most significant aspect of the $3 Billion settlement by global pharmaceutical giant GlaxoSmithKline LLC (GSK) was the Corporate Integrity Agreement (CIA), which restructures its sales and promotion practices. [read post]
2 Nov 2020, 1:41 pm
The Federal Circuit decision in GlaxoSmithKline LLC v. [read post]
27 Dec 2013, 6:36 am
GlaxoSmithKline even had a code name (“Vasily”) for its Botox-related bribery and kickback program, facilitated through travel agencies that doled out cash, luxury travel and even prostitutes to doctors. [read post]
16 Apr 2013, 8:30 pm
(collectively, “Biogen”)seek review of the district court’s construction ofthe disputed claim term “anti-CD20 antibody” that narrowedthe term based on prosecution history disclaimer.Under that construction, Biogen stipulated that it couldnot prove infringement by GlaxoSmithKline LLC andGlaxo Group Ltd. [read post]
25 Jan 2009, 2:36 pm
" Wyeth also has "plenty of lingering legal and patent expiration problems of its own," said Carol Levenson, an analyst with Gimme Credit LLC in Chicago, in a Jan. 23 note to clients. [read post]
6 Sep 2007, 8:13 am
GlaxoSmithKline, 484 F. [read post]
7 Dec 2023, 1:47 pm
I want to note here that the facts in this case are different from prior carve-out cases such as GlaxoSmithKline LLC v. [read post]
5 Aug 2009, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb) General Pharmaceutical patent settlements under fire on both sides of the Atlantic (GenericsWeb) Biotechnology… [read post]
8 Aug 2012, 4:20 am
© 2012 Simple Justice NY LLC. [read post]
18 Jan 2024, 9:16 am
The Federal Circuit explicitly limited its holding in GlaxoSmithKline LLC v. [read post]
12 Oct 2009, 12:29 am
"IPKat readers will recall that GlaxoSmithKline (and later joined by other biotech companies and universities) challenged the previous rules in 2007 in federal court. [read post]
15 Feb 2015, 12:58 pm
GlaxoSmithKline LLC, 713 F.3d 1090, 1095 (Fed. [read post]
2 Jul 2012, 11:57 am
In re Avandia Marketing, Sales Practices and Products Liability Litigation, No. 11-2664, decided June 28, 2012, the Third Circuit Court of Appeals reversed a district court decision (Eastern District of Pennsylvania)[2], which dismissed the claim of Humana Insurance Company (“Humana”) and other similarly situated providers of MAOs against GlaxoSmithKline, LLC and GlaxoSmithKline plc (collectively, “GSK”) for reimbursement of medical… [read post]
2 Jul 2012, 11:57 am
In re Avandia Marketing, Sales Practices and Products Liability Litigation, No. 11-2664, decided June 28, 2012, the Third Circuit Court of Appeals reversed a district court decision (Eastern District of Pennsylvania)[2], which dismissed the claim of Humana Insurance Company (“Humana”) and other similarly situated providers of MAOs against GlaxoSmithKline, LLC and GlaxoSmithKline plc (collectively, “GSK”) for reimbursement of medical… [read post]
14 Jul 2021, 8:09 pm
The background of the opinion describes the rather complex set of issues: We describe the facts in the light most favorable to the party that won the jury verdict (here, the plaintiffs). [read post]
8 Sep 2020, 6:56 am
GlaxoSmithKline LLC v. [read post]
